Discussions in pharmacological action and the development in clinical application of puer arin

Abstract

Abstract: As a saft and effective traditional Chinese medicine’s parenteral in jection, puerarin, whose molecular formula is 4,7-dihydroxy- 8β-D glucose isoflavone, has comprehensive and extensive phammaco logical action, and is generally used for treatment of cardiovascu lar and cerebrov ascular system diseases such as arhythmia, myocardial ischemia and hypertension.It has an extensive deve lopment perspective. The recent research in the mechanism of phamacological action and clinical application W ere review ed.

Key words: puerarn, pharmaoologic action, clinical application

CLC Number:

R965

YAO Dan, DING Xuan-sheng. Discussions in pharmacological action and the development in clinical application of puer arin[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(4): 468-474.

References

[1] Brayden JE. Membrane hyperpolanizat ion is a mechanism of endothei um-dependent cerebral vasodilation[J]. Am J Physiol,1990,259(3/2):H668-673.
[2] Mommbouli JV,V anhotte PM. Endothelium-derived hyperpolarizing factor(s):updating the unknown[J]. Trends Phamacol Sei,1997,18(7):252-256.
[3] Liu Q,Zhan LF,Li Z,et al. Effect of puerarin on the smooth muscles of the vesselsin rats and guineapigs[J].J Chin Med Univ,2005,31(6):401-403.
[4] William FJ. lon channels and vascular tone[J]. Hyper-tension,2005,35(2):1731.
[5] Yeung DK,Leung SW,Xu YC,et al. Puerarin,an isoflavonoid derived from Radix puerariae,pot ent iates endothelium-independent rel axation via the cydic AMP pathway in porcine coronary artery[J]. Eur J Phamacol,2006,552(1-3):105-111.
[6] 茅彩萍,顾振纶.葛根素对糖尿病大鼠主动脉糖基化终产物的形成及受体表达的影响[J].中国药理学通报,2004,20(4):393一397.
[7] Woff SP,Jiang ZY,Hunt JV. Protein glycat ion and oxidative stress in diabetes mel litus and ageing[J].Free Radic Biol Med,1991,10(5):339-352.
[8] Rembold CM. Regulation of contraction and relaxation in arterial smoth musde[J]. Hypertension,2004,20(2):129.
[9] Toda N,Kitamura Y,Okamura T. Neural mechanism of hypertension by nitric oxide synthase irhibitor in dog[J].Hypertension,1993,21(1):3-8.
[10] Nelon MT,Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle[J].Am J Physio,1995,268(4 Pt 1):C799-822.
[11] 马佳佳,马恒,王跃民,等.葛根素对大鼠腹主动脉的舒张作用及其机制[J].第四军医大学学报,2003,24(24):2231-2234.
[12] Wier WG,Balke CW. Ca(2+) release mechanisms,Ca(2+) sparks,and local control of excitationr contraction coupling in nomal heart muscle[J].Circ Res,1999,85(9):770-776.
[13] Hausenloy DJ,Maddock HL,BaxterGF,et al. nhibting mitochondial pemeability transition pore opening:a new paradigm for myocardial preconditioning[J]. Cardiovasc Res,2002,55(3):534-543.
[14] Cao CM,Chen M,Wong TM. The K(Ca) channel as a trigger for the cardi oprotection induced by kappa opioid receptor stimu lation its relationship w ith protein kinase C[J]. Br J Pharmacol,2005,145(7):984-991.
[15] 陈沪生,王培仁,邵建华,等.葛根素的降压效果及其机理的研究[J].山东医科大学学报,1987,25(3):28.
[16] Murply E. Primary and second ary signaling pathways in early preconditioning that converge on the mi tochondria to produce cardioprotection[J].Circ Res,2004,94(1):7-16.
[17] Fiordaliso F,De Angelis N,Bai A,et al. Effect fβ-adrenergic and renin angiotensin system block ade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats[J].lifeSci,2007,81(12):951-959.
[18] Ts libary EC. Microvascu lar basement membranes in diabetes melitus[J]. J Pat hol,2003,200(4):537-546.
[19] Duarte J,PerezVizcaino F,Utrilla P,et al. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure activity relationships[J]. Gen Pharmacol,1993,24(4):857-862.
[20] Xu YC,Leung SW,Yeung DK,et al. Structure activity relati onships of flavonoids for vascu lar relaxation in porcine coronary artery[J]. Phytochemisty,2007,68(8):1179-1188.
[21] 陈悦,黄霞,卫琮玲.葛根素对豚鼠乳头肌动作电位及延迟整流钾电流的影响[J].中国医学杂志,2006,41(10):747-749.
[22] Hocher B,Sdhwarz A,ReinbacherD,et al. Efects of endot helin receptor an tagonists on the p rogression of di abetic nephropathy[J].Nephron,2004,87(2):161.
[23] ManJin. Antioxidati ve components of Kudzu root[J].Nongop kwahak Yougu,2005,17(1):52-64.
[24] 范礼理,曾贵云,周远鹏,等.葛根的药理研究II:葛根黄酮对犬冠脉循环、心脏血流动力学和心肌代谢的作用[J].中华医学杂志,1975,55(10):724-726.
[25] Bruck dorfer,Richard. The basic about,nitric oxide[J].MolAspects Med,2005,26(1/2):3-31.
[26] 吕欣然,高尔,许兰芝,等.葛根素对含β2 肾上腺素受体的离体器官和整体动物的阻断作用[J].中国药理学报,2006,7(6):537-539.
[27] 康胜群,赵淑健,赵文惠,等.葛根素对糖尿病肾病的临床观察[J].临床荟萃,2002,17(8):440-441.
[28] Yu Z,li W. Induction of apoptosis by puerarin in colon cancerHT-29 cell[J]. Cancer Lett,2006,238(1):53-60.
[29] FiordalisoF,Li B,Latini R,et al. Myocyte death in strep-tozotocin induced diabetes in rats in angiotensin IH dependent[J].Iab Invest,2005,80(4):513-527.
[30] 董丽萍.葛根对免疫机制的作用[J].中国药理学报,1998,19(4):339-341.
[31] Ajar M,Gilani AH,Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aort a[J]. Life Sci,2005,74(5):603-612.
[32] 张雷,陈立梅,倪红霞,等.葛根素影响链脲佐菌素诱导糖尿病大鼠脂肪细胞葡萄糖转运蛋白4的表达[J].中国临床康复,2006,10(39):135-138.
[33] Zhao ZQ. Oxidative stress elicited myocardial apoptosis during repefusion[J].Cur Opin Pharmacol,2004,4(2):159-165.
[34] GaoQ,Yang B,Ye ZG,et al. Opening the calcium acivated potassium channel patici pates in the cardiop rotective effect of puerarin[J].EurJ Pharmacol,2007,574(2/3):179-184.
[35] Moriarty K,Kim KH,Bender JR. Minireview:est rogen receptomediated rapid signaling[J].Endocrinology,2006,147(12):5557-5563.
[36] Xu XH. Effects of puerarin on fatty superoxide in aged mice induced byD galactose[J].Chin J Chin Mater Med,2003,28(1):66-69.
[37] Gao Q,Yang B,Ye ZG,et al. Opening the calciumr adivated potassium channel patici pates in the cardiop notective effect of puerarin[J. Eur J Phamacol,2007,574(2/3):179-184.
[38] Ma Z,Wu Q,Lee DY,et al. Detem ination of puerarin in human plasma by h igh perfomance liquid chromatography[J].J Chromatogr B Analyt Technol Biomed Life Sci,2005,823(2):108-114.
[39] Yan B,Xing D,Ding Y,et al. HPIC method for the detemination and phamacokinetic studies on puerarin in cerebral ischemia reperf usion rat plasma after int ravenous administ ration of puerariae radix isoflavone[J].J Pham Biomed Anal,2005,37(2):297-301.
[40] Shen J,Meng Z,Su H,et al Diferent ki netics of puerarin in plasma of normal and depressed rats after oral admiristration of Chinese medicine TZ18[J].Tsinghua Science.and Techology,2007,6(20):394-399.
[41] 薛海英,王志建.葛根素治疗冠心病心绞痛疗效观察[J].现代中西医结合杂志,2003,12(10):1031-1032.
[42] 高秀荣,王春梅,秦桂云,等.葛根素注射液改善冠心病微循环的临床观察[J].中国微循环,2004,6(4):216-217.
[43] 吴慧轩.葛根素注射液治疗高脂血症疗效观察[J].中国中医药信息杂志,2003,10(7):49-50.
[44] 高凤英. 葛根素药理作用的研究进展[J].中草药,2003,34(10):81.
[45] 李小鹰,王培仁,邵建会.葛根素对急性心肌梗死者梗死范围的影响[J].中华心血管杂,2005,13(3):175-176.
[46] 陈阳,李红君.葛根素治疗外伤后脑梗死[J].中国中西医结合外科杂志,2005,8(3):220-221.
[47] 赵慧娟,罗贵军.葛根素治疗2型糖尿病的疗效观察[J].实用中西医结合临床,2005,5(1):23.